Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001531178-25-000007

Options or other derivatives

  • Director acquired 35,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Edick Paul R Director 2025-10-27 Grant or award · Stock Option (Right to Buy) +35,200 35,200 D: show line 1 in the form
Loading xslF345X05/form4-11042025_091145.xml…